Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention

Johnson & Johnson to collaborate with Apple to assess impact of wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes

Up to 30 percent of AFib cases go undiagnosed until life-threatening complications occur, signaling a critical need for more efficient and scalable screening methods.

 

The study aims to analyze the impact of Apple Watch on the early detection and diagnosis of AFib, and the potential to improve outcomes including the prevention of stroke. A multi-year research program will be launched later in 2019. This large-scale program will occur in the U.S. only, and will be designed as a pragmatic randomized controlled research study for individuals age 65 years or older.

The study’s goals include:

  • Measuring the outcomes of a heart health engagement program with irregular rhythm notifications on Apple Watch.
  • Assessing the impact of a medication adherence program using an app from Johnson & Johnson.

About AFib
AFib is an irregular heartbeat that can lead to the formation of blood clots resulting in stroke, heart failure and other potentially devastating complications. AFib is the most common sustained arrhythmia, increases stroke risk five-fold, and accounts for almost one-third of all strokes.[ii] Because blood clots formed in the heart can be large, AFib-caused strokes tend to damage large areas of the brain, which typically leads to a higher risk of death, significant damage and increased cost of treatment and care. Around 20% of individuals who experience a stroke were not aware of their underlying AFib condition.[iii]

About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

About the Janssen Pharmaceutical Companies of Johnson & Johnson 
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com. Follow us at @JanssenGlobal. Janssen Pharamaceuticals, Inc. is part of the Janssen Pharmaceutical Companies of Johnson & Johnson.

For more information visit : https://johnsonandjohnson.gcs-web.com/news-releases/news-release-details/johnson-johnson-announces-research-study-apple-watch-help